Cardio-Rheumatic Diseases: Inflammasomes Behaving Badly

Area of Science:

• Cardio-rheumatology
• Immunology
• Cardiovascular Medicine

Background:

• Cardio-rheumatology integrates rheumatology and cardiovascular medicine, highlighting increased cardiovascular disease (CVD) risk in autoimmune/inflammatory rheumatic conditions.
• Inflammasomes are immune system multiprotein complexes crucial for innate immunity, involving NF-κB, caspase 1, and pro-inflammatory cytokines like IL-18 and IL-1β.
• Dysregulated inflammasome activation is linked to various inflammatory diseases.

Purpose of the Study:

• To review inflammasome activation mechanisms.
• To explore the role of inflammasomes in the pathogenesis of cardiovascular diseases (CVDs).
• To illustrate inflammasome involvement in specific rheumatic diseases and their cardiovascular implications.

Main Methods:

• Literature review focusing on inflammasome activation pathways.
• Analysis of studies investigating inflammasomes in cardiovascular disease.
• Examination of inflammasome roles in rheumatic heart disease, Kawasaki disease, familial Mediterranean fever, ankylosing spondylitis, and rheumatoid arthritis.

Main Results:

• Inflammasomes are implicated in the inflammatory cascades driving CVD pathogenesis.
• Specific rheumatic conditions demonstrate the link between inflammasome activation and cardiovascular complications.
• Targeting inflammasomes presents a potential therapeutic strategy for managing inflammatory CVDs.

Conclusions:

• Inflammasome dysregulation is a significant factor in the development of cardiovascular diseases, particularly in the context of rheumatic conditions.
• Understanding inflammasome pathways provides insights into the pathobiology of various inflammatory and cardiovascular diseases.
• Targeting inflammasomes may offer novel therapeutic avenues for cardio-rheumatologic disorders.